Integrin α9β1, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG

Search, find, compare suppliers for anti-Integrin α9β1, Human antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityIntegrin α9β1, Human
CloneREA483
Host SpeciesRecombinant Human
Reactive Specieshuman, other
IsotypeIgG1
Formatphycoerythrin (PE) conjugate
Size100 tests in 200 µL
Concentration1:50
ApplicationsFlow cytometry
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionIntegrin α9β1 Antibody, anti-human, PE, REAfinity™. Clone REA483 recognizes the human integrin α9β1 antigen, a single-pass type I membrane protein which is also known as integrin alpha-RLC. Integrins are heterodimeric glycoprotein receptors and exist as non-covalently bound α and β subunits. The integrin α9β1 binds a number of extracellular matrix components like VCAM1, cytotactin, and osteopontin to mediate cell adhesion, migration, and tissue invasion. Although widely expressed in a variety of normal human cells including endothelium, different types of muscle cells, hepatocytes, and in the hematopoietic system, it is also expressed in cancer cells. Expression of integrin α9β1 in human cancers appears to correlate with higher grade tumors. | Additional information: Clone REA483 displays negligible binding to Fc receptors.
Immunogenn/a
Other NamesITGA9B1, ITGA9, ITGA-RLC, ITGB1
Gene, Accession #Gene ID: 3680, 3688
Catalog #130-132-366
Price$354
Order / More InfoIntegrin α9β1, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Product Specific ReferencesKanayama, M. et al. (2011) α9β1 integrin-mediated signaling serves as an intrinsic regulator of pathogenic T?17 cell generation. J Immunol 187 (11): 1271-1281. | Gupta, S. K. et al. (2013) Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition. Oncogene 32 (2): 141-150. | Ota, D. et al. (2014) Tumor-α9β1 integrin-mediated signaling induces breast cancer growth and lymphatic metastasis via the recruitment of cancer-associated fibroblasts. J. Mol. Med. 92 (12): 1271-1281.
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197

macs@miltenyibiotec.de

https://www.miltenyibiotec.com

Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.